These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37022767)

  • 21. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diffusion of screening programmes in Italy, year 2009.
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study.
    Njor SH; Søborg B; Tranberg M; Rebolj M
    Prev Med; 2023 Feb; 167():107405. PubMed ID: 36581010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    Onega T; Garcia M; Beaber EF; Haas JS; Breslau ES; Tosteson ANA; Halm E; Chao CR; Barlow WE
    J Gen Intern Med; 2024 Jun; 39(8):1324-1331. PubMed ID: 38097863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
    Chiereghin A; Squillace L; Pizzi L; Sanna T; Bazzani C; Roti L; Mezzetti F
    Epidemiol Prev; 2024; 48(2):158-164. PubMed ID: 38770733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
    Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
    Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
    Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
    BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G; Chattopadhyay S
    JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent participation in screening for cervical, breast, and bowel cancer in England.
    Rebolj M; Parmar D; Maroni R; Blyuss O; Duffy SW
    J Med Screen; 2020 Mar; 27(1):9-17. PubMed ID: 31525303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer.
    Whitham HK; Kulasingam SL
    Prev Med; 2015 Jul; 76():135-40. PubMed ID: 25937628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance.
    Venturelli F; Sampaolo L; Carrozzi G; ; Zappa M; Giorgi Rossi P
    Prev Med; 2019 Mar; 120():60-70. PubMed ID: 30659908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
    Charkhchi P; Schabath MB; Carlos RC
    J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R
    Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.